RecruitingNot ApplicableNCT05537129

Laparoscopic vs Open Total Gastrectomy for Gastric Cancer

A Prospective, Multicentral, Open-label, Randomized, Controlled Clinical Trial to Compare the Survival, Morbidity and Mortality of Laparoscopic and Open Total Gastrectomy for Gastric Cancer


Sponsor

Fudan University

Enrollment

600 participants

Start Date

Oct 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the present study is to demonstrated the the safety and feasibility of laparoscopic total gastrectomy comparing with open total gastrectomy.


Eligibility

Min Age: 20 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two surgical approaches for removing the stomach (total gastrectomy) in patients with gastric cancer: laparoscopic (keyhole) surgery versus traditional open surgery. The goal is to determine whether the less invasive keyhole approach has similar cancer outcomes with fewer complications and faster recovery. **You may be eligible if:** - You are between 20 and 80 years old - You have been confirmed (by biopsy) to have stomach cancer in the upper or middle part of the stomach - Your cancer is classified as stage I–III (not involving distant organs) - Your general health is good (ECOG score 0–1) - You are scheduled for a total gastrectomy (full stomach removal) with lymph node removal - You have not received chemotherapy or radiation before surgery **You may NOT be eligible if:** - Your cancer is at an advanced stage (N3 lymph node involvement or T4b) - You have received pre-operative chemotherapy or radiation - You have had previous stomach surgery - You have another active cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETotal Gastrectomy

The laparoscopic or open total gastrectomy with D2 lymphadenectomy was performed according to the Japanese gastric cancer treatment guidelines.


Locations(1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05537129


Related Trials